Innovative Seborrhea Treatments on the Horizon as Pipeline Report Reveals Promising Drug Candidates for 2024
26 avr. 2024 04h36 HE
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Seborrhea - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Seborrhea, a chronic skin condition often...
Cryopyrin-Associated Periodic Syndrome Drug Pipeline Report 2024: Therapeutic Developments for Zydus Cadila, Novartis, Inflazome, Roche, Aclaris Therapeutics, and Mabpharm
25 avr. 2024 07h43 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Cryopyrin-Associated Periodic Syndrome - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offeringThe global medical...
Autoimmune Collaboration and Licensing Deals Report 2024: Provides Details of 882 Autoimmune Deals Dating Back to 2016 by Company, Headline Value, Therapeutic Area and Technology Type
24 avr. 2024 04h24 HE
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Autoimmune Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Autoimmune Collaboration and...
Maveropepimut-S (MVP-S, previously known as DPX-Survivac) Drug Research Report 2024: 7 Major Markets Size, Forecasts, and Emerging Insights 2019-2032
17 avr. 2024 09h37 HE
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "DPX-Survivac Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
China Hydronidone (F-351) Market Size, Forecast, and Emerging Insights, 2019-2023 and 2024-2032
16 avr. 2024 05h03 HE
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "China F-351 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."F-351 Market Size,...
Ovarian Cancer Opportunity Assessment Report 2024: A Blockbuster Market that is Expected to Grow from $3.3 Billion in 2022 to $4.1 Billion in 2032 with ImmunoGen, AstraZeneca, Merck, & GSK Dominating
09 avr. 2024 07h02 HE
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering.Ovarian Cancer is one of the most...
COSENTYX (Secukinumab) Market Analysis and Outlook 2019-2032: Mechanism, Dosage, Research, Sales, Regulatory Milestones, Patents, SWOT Analysis
02 avr. 2024 11h47 HE
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "COSENTYX Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Autoimmune Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034
25 mars 2024 19h44 HE
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Autoimmune Uveitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ResearchAndMarkets.com's offering. ...
Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034
25 mars 2024 19h43 HE
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Cutaneous Lupus Erythematosus (CLE) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ...
Lupus Nephritis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034
25 mars 2024 19h42 HE
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Lupus Nephritis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ResearchAndMarkets.com's offering.A...